Skip to content

Academic GI Cancer Consortium (AGICC)​

Collaboration & Innovation in Cancer Research

The Academic GI Cancer Consortium (AGICC) is presently represented by Key Opinion Leaders (KOLs) and Top Investigators at the most prestigious institutions in the USA.
It represents an innovative research model that brings together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal (GI) cancers.

"Today, every cancer is a "rare tumor" due to its unique molecular characteristics, requiring teams of experts with the experience and knowledge to tackle these distinct problems. AGICC is up to the challenge, carrying out cutting edge clinical trials and ultimately improving patient outcomes."

Wells Messersmith, MD, AGICC Director
Academic GI Cancer Consortium (AGICC) - Criterium - Global CRO - Clinical Trial Services